tert-Butyl 7-((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methylene)-2-azaspiro[3.5]nonane-2-carboxylate

Catalog No. :
ACLDGU294
CAS No. :
2763648-39-9
Molecular Formula :
C20H34BNO4
Molecular Weight :
363.31

IUPAC Name:tert-butyl 7-((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methylene)-2-azaspiro[3.5]nonane-2-carboxylate

tert-Butyl 7-((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methylene)-2-azaspiro[3.5]nonane-2-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 7-((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methylene)-2-azaspiro[3.5]nonane-2-carboxylate
IUPAC Nametert-butyl 7-((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methylene)-2-azaspiro[3.5]nonane-2-carboxylate
Molecular FormulaC20H34BNO4
Molecular Weight363.31
SMILESO=C(N1CC2(CCC(CC2)=CB3OC(C)(C)C(C)(C)O3)C1)OC(C)(C)C
InChI KeyNWCVTZNMMFRZSP-UHFFFAOYSA-N
Synonymtert-butyl 7-[(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methylene]-2-azaspiro[3.5]nonane-2-carboxylate;2-Azaspiro[3.5]nonane-2-carboxylic acid, 7-[(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methylene]-, 1,1-dimethylethyl ester
CAS No.2763648-39-9

Synthetic Route by SureRoute

1. ACLDGU294 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKYMO387 route compound structure diagram
    ACKYMO3871363381-22-9 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLDGU294 route product structure diagram
    ACLDGU2942763648-39-9
Inquiry

2. ACLDGU294 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  4. Then
  5. ACLDGU294 route product structure diagram
    ACLDGU2942763648-39-9
Inquiry

Comments (0)